LENSAR Inc (LNSR)
7.28
-0.17
(-2.28%)
USD |
NASDAQ |
Nov 22, 13:42
LENSAR Total Liabilities (Quarterly): 39.28M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 39.28M |
June 30, 2024 | 37.76M |
March 31, 2024 | 34.30M |
December 31, 2023 | 36.16M |
September 30, 2023 | 34.47M |
June 30, 2023 | 38.51M |
March 31, 2023 | 12.52M |
December 31, 2022 | 13.86M |
September 30, 2022 | 12.22M |
Date | Value |
---|---|
June 30, 2022 | 13.80M |
March 31, 2022 | 10.49M |
December 31, 2021 | 11.59M |
September 30, 2021 | 11.06M |
June 30, 2021 | 10.86M |
March 31, 2021 | 9.214M |
December 31, 2020 | 11.91M |
September 30, 2020 | 11.76M |
December 31, 2019 | 65.09M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.214M
Minimum
Mar 2021
65.09M
Maximum
Dec 2019
23.05M
Average
13.16M
Median
Total Liabilities (Quarterly) Benchmarks
Standard BioTools Inc | 192.21M |
Ainos Inc | 13.35M |
Zomedica Corp | 11.27M |
Intelligent Bio Solutions Inc | 5.777M |
Adagio Medical Holdings Inc | 14.76M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 62.02M |
Shareholders Equity (Quarterly) | 22.74M |
Current Ratio | 3.374 |